Indian Pharmaceutical Alliance.
association of domestic Indian pharmaceutical companies
- Reports this week
- 0
- Active events
- 0
- Connections
- 9
What's happening
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
What's reaching Indian Pharmaceutical Alliance
Events traced to Indian Pharmaceutical Alliance, step by step, newest firstAround Indian Pharmaceutical Alliance this week
News at the entities that move Indian Pharmaceutical Alliance most-
Government of India StructuralSEBI proposed tax changes for Indian equities, with HDFC Securities providing financial services and the Government of India retaining final decision.Moves Indian Pharmaceutical Alliance
-
Centre StructuralThe Centre filed a status report with the Delhi High Court on November 3, 2026.Moves Indian Pharmaceutical Alliance
-
Donald Trump StructuralTrump's bill is pushing unfunded costs onto the state, affecting Lewis County, where Tim Hunt serves as County Manager.Moves Indian Pharmaceutical Alliance
-
Nomura Mentioned togetherNomura provided financial analysis regarding Nasdaq options.Moves Indian Pharmaceutical Alliance
Connections
The 5 strongest of 9, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sudarshan Jain Structural
Sudarshan Jain serves as the Secretary General/Director General of the Indian Pharmaceutical Alliance.
-
Government of India Structural
The alliance relies on the government for its operational environment, while providing crucial industry input to policy formation.
-
Centre Structural
The Centre exercises regulatory authority over the pharmaceutical industry, including amending drug price control orders, which directly impacts the work of the Indian Pharmaceutical Alliance.
-
Donald Trump Structural
Donald Trump's policies and administration actions structurally influence the market interests of the Indian Pharmaceutical Alliance.
-
Nomura Mentioned together
Both entities are related to the broader trend of Indian companies moving production to the U.S.